COMMUNIQUÉS West-GlobeNewswire

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

20/09/2019 - 07:00

Roche is dedicated to helping save patients’ lives by delivering state-of-the-art solutions to aid in the protection of the global blood supply from infectious diseases If undetected, Babesia infection can be fatal in [...]

IBA subsidiary, Normandy Hadrontherapy, launches development of carbon therapy system in Normandy, France

20/09/2019 - 07:00

Louvain-La-Neuve, Belgium, 20 September 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the launch of the [...]

Normandy Hadrontherapy, filiale d'IBA, lance le développement d'un système de traitement par carbone en Normandie, en France

20/09/2019 - 07:00

Louvain-La-Neuve, Belgique, 20 septembre 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce le lancement aujourd'hui du [...]

InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering

20/09/2019 - 03:12

TEL AVIV, Israel, Sept. 19, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, [...]

XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)

20/09/2019 - 03:00

● TMX-049 Results Show Beneficial Decrease of Urinary Albumin in T2DN ● CALGARY, Alberta, Sept. 19, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a [...]

Psychemedics Corporation Announces New Brazilian Distribution Agreement

19/09/2019 - 23:25

ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with Toxicologia [...]

CV Sciences, Inc. Announces Plans to File Request For Continued Examination of Its US Patent Application

19/09/2019 - 23:17

SAN DIEGO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today [...]

Align Technology Announces Global Distribution Agreement With Zimmer Biomet Dental For Itero Element® Intraoral Scanners

19/09/2019 - 22:15

Partners with Global Implant and Restorative Dentistry Leader to Increase Penetration of iTero Scanners SAN JOSE, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced a global [...]

Globus Medical Showcases Latest Innovations at NASS 2019

19/09/2019 - 22:15

Technologies featured include Single Position Lateral Surgery driven by ExcelsiusGPS® Interbody Solutions AUDUBON, Pa., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal [...]

Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes

19/09/2019 - 22:05

NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients [...]

Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research

19/09/2019 - 22:01

Data reinforce the scientific evidence supporting the potential treatment of chronic pruritic diseases through OSMRβ inhibition HAMILTON, Bermuda, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq [...]

HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock

19/09/2019 - 22:01

TUCSON, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it intends to offer and [...]

Galapagos increases share capital through warrant exercises

19/09/2019 - 22:01

Mechelen, Belgium; 19 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 301,745 new [...]

Transparency notification

19/09/2019 - 22:01

Mechelen, Belgium; 19 september 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Sands Capital Management, LLC . Pursuant to Belgian [...]

Monthly information regarding the total number of voting rights and total number of shares of the Company

19/09/2019 - 22:00

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

19/09/2019 - 22:00

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks

19/09/2019 - 19:18

SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announces it [...]

Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy

19/09/2019 - 18:13

Study Uses NGS Data with Biosimulation to Predict Drug Response in AML and MDS Patients SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of [...]

Genkyotex Announces First Half 2019 Results

19/09/2019 - 18:00

Final setanaxib phase 2 results in PBC showed statistical significance for primary endpoint when corrected for non-normal variability Data to be presented at an upcoming international scientific conference WHO [...]